| 885 |
decreased |
protein import into nucleus, translocation
(GO:0000060)
|
zinc finger protein GLI1
(PR:000008026)
|
2028: Decrease, GLI1/2 translocation to nucleus
|
| 884 |
decreased |
protein import into nucleus, translocation
(GO:0000060)
|
zinc finger protein GLI1 (human)
(PR:P08151)
|
None
|
| 883 |
decreased |
regulation of receptor activity
(GO:0010469)
|
smoothened
(PR:000015288)
|
2027: Antagonism, Smoothened receptor
|
| 882 |
decreased |
|
smoothened
(PR:000015288)
|
None
|
| 881 |
decreased |
receptor antagonist activity
(GO:0048019)
|
smoothened homolog (human)
(PR:Q99835)
|
None
|
| 880 |
occurrence |
cellular response to exogenous dsRNA
(GO:0071360)
|
RNA viral genome
(GO:0019022)
|
1901: Interferon-I antiviral response, antagonized by SARS-CoV-2
|
| 879 |
decreased |
type I interferon signaling pathway
(GO:0060337)
|
interferon beta
(PR:000024939)
|
1901: Interferon-I antiviral response, antagonized by SARS-CoV-2
|
| 878 |
decreased |
type I interferon signaling pathway
(GO:0060337)
|
interferon alpha
(PR:000024938)
|
1901: Interferon-I antiviral response, antagonized by SARS-CoV-2
|
| 877 |
occurrence |
endocytosis involved in viral entry into host cell
(GO:0075509)
|
cathepsin L1 (human)
(PR:P07711)
|
1738: SARS-CoV-2 cell entry
|
| 876 |
occurrence |
membrane fusion
(GO:0061025)
|
transmembrane protease serine 2
(PR:000016456)
|
1738: SARS-CoV-2 cell entry
|
| 875 |
occurrence |
membrane fusion
(GO:0061025)
|
host cell membrane
(GO:0033644)
|
None
|
| 874 |
occurrence |
protease binding
(GO:0002020)
|
transmembrane protease serine 2
(PR:000016456)
|
None
|
| 873 |
occurrence |
endocytosis involved in viral entry into host cell
(GO:0075509)
|
host cell membrane
(GO:0033644)
|
None
|
| 872 |
occurrence |
receptor binding
(GO:0005102)
|
angiotensin-converting enzyme 2
(PR:000003622)
|
1739: Binding to ACE2
|
| 871 |
increased |
Malignant mesothelioma
(HP:0100001)
|
mesothelioma
(MESH:D008654)
|
1090: Increased, mesotheliomas
|
| 870 |
increased |
toll-like receptor 4 signaling pathway
(GO:0034142)
|
Toll-like receptor 4
(PR:000001155)
|
1495: Substance interaction with the lung resident cell membrane components
|
| 869 |
increased |
toll-like receptor signaling pathway
(GO:0002224)
|
Toll-like receptor
(PR:000001096)
|
1495: Substance interaction with the lung resident cell membrane components
|
| 868 |
increased |
pattern recognition receptor signaling pathway
(GO:0002221)
|
|
1495: Substance interaction with the lung resident cell membrane components
|
| 867 |
increased |
increased lung tumor incidence
(MP:0008014)
|
lung
(UBERON:0002048)
|
1670: Lung cancer
|
| 866 |
increased |
Neoplasm of the lung
(HP:0100526)
|
lung
(UBERON:0002048)
|
1670: Lung cancer
|
| 865 |
increased |
cell proliferation
(GO:0008283)
|
mesothelial cell
(CL:0000077)
|
870: Increase, Cell Proliferation
|
| 864 |
increased |
abnormal DNA repair
(MP:0008058)
|
DNA repair complex
(GO:1990391)
|
1669: Increased, DNA damage and mutation
|
| 863 |
increased |
chromosomal instability
(MP:0008866)
|
chromosome
(GO:0005694)
|
2 Events
|
| 862 |
increased |
chromosome breakage
(GO:0031052)
|
chromosome
(GO:0005694)
|
2 Events
|
| 861 |
increased |
mutation
(MESH:D009154)
|
|
1669: Increased, DNA damage and mutation
|